Higher trends within Pain Management Devices applications including chronic pain treatment, surgical pain control and home healthcare solutions; and other key wide areas like chronic pain treatment and surgical pain control are expected to push the market to $12.2 billion by 2035 from $4.4 billion of 2023.
TENS devices (Transcutaneous Electrical Nerve Stimulation) are commonly used in hospitals and home care setups for lasting pain issues like lower back pain and nerve related pain conditions such as neuropathic pain. Major companies like Medtronic and Boston Scientific developed devices that utilizes modern technologies to deliver precise pain alleviation treatments. In medical settings like surgeries, procedures utilize drug delivery systems to manage post surgical pain levels effectively in a precise manner without the risks of excessive use and negative effects often linked with opioid medications. Companies such as Abbott are delivering devices with advancing technologies that aid by addressing pain through secure and regulated methods
Detailed Analysis - https://datastringconsulting.com/industry-analysis/pain-management-devices-market-research-report
The shift in the approach towards invasive methods for handling pain is revolutionizing the way the industry works these days. Patients as well as the healthcare givers are now opting for pain management tools that offer effective and efficient pain relief with minimal risks and complications instead of surgery and opioids.
Industry Leadership and Strategies
The Pain Management Devices market within top 3 demand hubs including U.S., Germany and UK, is characterized by intense competition, with a number of leading players such as Medtronic, Boston Scientific, Abbott, Smiths Medical, Nevro Corp, B. Braun Melsungen AG, DJO Global, Omron Healthcare, Stimwave LLC, BioWave, Stryker Corporation and Nuvectra Corporation. Below table summarize the strategies employed by these players within the eco-system.
This market is expected to expand substantially between 2024 and 2030, supported by market drivers such as aging population and chronic diseases, technological advancements in pain relief, and shift toward non-opioid therapies.
Regional Analysis
Research Study analyse the global Pain Management Devices market in detail and covers industry insights & opportunities at Product Type (Electrical Stimulation Devices, Radiofrequency Ablation Devices), Application (Neuropathic Pain, Cancer Pain, Musculoskeletal Pain) and End-User (Hospitals, Ambulatory Surgical Centers, Others) for more than 20 countries.
About DataString Consulting
DataString Consulting assist companies in strategy formulations & roadmap creation including TAM expansion, revenue diversification strategies and venturing into new markets; by offering in depth insights into developing trends and competitor landscapes as well as customer demographics. Our customized & direct strategies, filters industry noises into new opportunities; and reduces the effective connect time between products and its market niche.
DataString Consulting offers complete range of market research and business intelligence solutions for both B2C and B2B markets all under one roof. DataString’s leadership team has more than 30 years of combined experience in Market & business research and strategy advisory across the world. Our Industry experts and data aggregators continuously track & monitor high growth segments within more than 15 industries and 60 sub-industries.